Rising Incidence of Rare Diseases Spurs Growth in Newborn Screening Market

The report provides a detailed summary of the Global Newborn Screening Market, market definition, size, share, classifications, applications, end-users, industry verticals, and the industry chain structure. The statistical surveying report also provides an in-depth analysis of the market dynamics, development trends, competitive analysis, potential growth opportunities, technological advancements and inventions, and the regional analysis. The development policies and plans have been mentioned, along with the manufacturing processes and the overall cost structure.

The report "Newborn Screening Market by Product (Instrument, Consumables), Test Type (Dried Blood Spot, Hearing Screening, CCHD), Technology (Tandem Mass Spectrometry, Immunoassay, Enzyme Assay, Molecular, Pulse Oximetry), End User (Hospitals) - Global Forecast to 2026" The global newborn screening market size is projected to reach USD 1.3 billion by 2026 from USD 0.9 billion in 2021, at a CAGR of 8.3%. Growth in this market is driven mainly by the grwoing awareness regarding early diagnosis of diseases in newborn, rising newborn screen rate, favourable  government policies to conduct newborn screening.

Download a PDF Copy: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=141676244

The report provides a detailed analysis of the current competitive landscape, including company profiles, product portfolio and specification, production, price, cost structure, production value and volume, and contact information. Upstream raw materials and downstream demand analysis has also been carried out in this meticulous study. All the distribution and marketing channels have been analyzed in this report.

The leading competitors functioning in the Global Newborn Screening Market are focusing on expansions, product launches, mergers and acquisitions, partnerships, and divestitures as their key business strategy to survive in the competitive market. The report gathers and studies the industry players and their strategic moves to sustain in this market.

Some of the major players in the newborn screening market include Some of the leading players in the newborn screening market are PerkinElmer (US), Demant A/S (Denmark), Natus Medical (US), Bio-Rad Laboratories (US), Danaher Corporation (US), and Medtronic (Ireland). Others include Chromsystems Instruments & Chemicals GmbH (Germany), Trivitron Healthcare (India), Baebies (US), Parseq Lab (Russia), and Recipe Chemicals+Instruments (Germany).

PerkinElmer is the leading player in the newborn screening market. The company offers a wide range of instruments and consumables for screening newborns. In the last three years, the company has been focusing on organic and inorganic strategies to maintain its leading position in the newborn screening market. The company has a strong presence in the Americas; in 2019, it registered ~39% of its total revenue from the Americas alone.

 

Demant is the second-leading player in the newborn screening market and a leading player in the newborn hearing screening segment. The company offers a wide range of newborn hearing screening instruments. With a strong footprint across North America and Europe and subsidiaries and distribution channels, the company has maintained a leading position in the hearing screening segment. It generated ~42% of its total revenue from North America in 2019.

The report provides a detailed assessment of the market by means of an in-depth quantitative and qualitative analysis, historical data, and verifiable projections about the market size. The assessments featured in this report have been derived using research methodologies, proper assumptions and decision-making. With the arrival of newer market products, M&A, and service extensions, the competitive landscape in the market will intensify further. Strategic alliances are being formed to manufacture and market products more vigorously and efficiently.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=141676244

This research report categorizes the global newborn screening market into the following segments and sub-segments:

By Product

·         Consumables

o   Assay kits & reagents

o   Other consumables ( columns and screening cards)

·         instruments

o   Disorder screening instruments

§  Fully automated instruments

§  Other instruments (sei-automated instruments, shakers, incubator and etc.)

·         Hearing screening instruments

o   Accessories

o   Devices

·         Pulse oximeters

By Test

·         Dry blood spot tests

·         Hearing screening tests

·         CCHD screening tests

By technology

·         Immune assays & enzymatic assays

·         Tandem mass spectrometry

·         Molecular assays

·         Hearing screening technologies

·         Pulse oximetry

·         Other Technologies (Fluorescence, gel electrophoresis etc.)

By End User

·         Clinical Laboratories

·         Hospitals

Some of the key geographies mentioned in this report include:

·         North America (U.S and Canada and rest of North America)

·         Europe (Germany, France, Italy and Rest of Europe)

·         Asia-Pacific (China, Japan, India, South Korea and Rest of Asia-Pacific)

·         LAMEA (Brazil, Turkey, Saudi Arabia, South Africa and Rest of LAMEA)

North America accounted for the largest share of the newborn screening market

The market, by region, has been segmented into North America, Europe, the Asia Pacific, and the Rest of the world (RoW). North America is the largest market for newborn screening, followed by Europe. Growth in the North American market can be attributed to the availability of newborn screening programs, favorable reimbursement policies, and a strong market player presence.

The Asia Pacific is expected to register the highest CAGR during the forecast period. Growth in this region is driven by the large newborn pool, increasing screening rate, and rising awareness regarding early diagnosis.

Reasons to Purchase the Report:

·         To comprehend the impact of the end-user applications on the Global Newborn Screening Market.

·         Study the various prospects of the Global Newborn Screening Market by Porter’s Five Forces Analysis.

·         Detailed evaluation of the financial information, market size, share, value, volume, and cost.

·         Regions and countries expected to dominate and witness the fastest growth of the market.

·         Study the technological advancements, inventions, key developments, and market strategies followed by the leading market competitors.

Content Source:

https://www.marketsandmarkets.com/Market-Reports/newborn-screening-market-141676244.html

https://www.marketsandmarkets.com/PressReleases/newborn-screening.asp

https://www.marketsandmarkets.com/ResearchInsight/newborn-screening-market.asp

https://www.globenewswire.com/en/news-release/2022/12/15/2574296/0/en/Newborn-Screening-Market-worth-1-3-billion-by-2026-Exclusive-Report-by-MarketsandMarkets.html

https://www.prnewswire.com/news-releases/newborn-screening-market-worth-1-3-billion-by-2026--exclusive-report-by-marketsandmarkets-301236393.html 

Comments

Post a Comment

Popular posts from this blog

From Pain Management to Drug Delivery: The Rising Trajectory of Transdermal Patches

Image
The global transdermal patches market is poised for significant expansion in the coming years, projected to grow from $6.2 billion in 2023 to $8.0 billion by 2029 at a compound annual growth rate (CAGR) of 4.5%. This burgeoning market is driven by several key factors, including the rising prevalence of chronic diseases, the increasing adoption of analgesic patches, technological advancements in transdermal patch development, and a shift away from traditional injections toward more convenient and patient-friendly transdermal delivery systems. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=190809043 One of the primary driving forces behind this growth is the growing popularity of analgesic patches for pain management. These patches offer a localized and controlled release of painkillers through the skin, reducing the risk of systemic adverse effects associated with oral medications. Patients with chronic pain disorders are increasingly turning to anal...
Read more

Introducing the Future of Beauty: Cutting-Edge Medical Aesthetics Treatments

Image
Introduction to Medical Aesthetics: Medical aesthetics is a field of medicine that focuses on improving the appearance of the body through various treatments, such as laser treatments, chemical peels, injectables, and fillers. It is a combination of medical and cosmetic treatments, which are designed to enhance a patient’s natural beauty, while also addressing any health concerns a patient may have. Medical aesthetics has become increasingly popular in recent years, as more people seek to improve their appearance and overall health. The benefits of medical aesthetics treatments are numerous. Patients can achieve a more youthful and vibrant look, improve skin tone and texture, reduce wrinkles and fine lines, correct discoloration and sun damage, and even out skin tone. Additionally, medical aesthetic treatments can help with body contouring and scarring, as well as providing a boost to self-confidence. The results of medical aesthetic treatments can last for many months or even yea...
Read more

Scaffold Products Lead Tissue Engineering Market Growth, Driven by Orthopedic Applications

The global tissue engineering market is projected to expand from $4.4 billion in 2023 to $8.9 billion by 2028, representing a strong CAGR of 15.3%. Key growth drivers include the rising need for advanced regenerative medicines to treat chronic and degenerative diseases, as well as increasing incidence of traumatic injuries from accidents. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=34135173 While high treatment costs currently restrain market growth, exciting technological advancements like 3D bioprinting, organ-on-chip technology, and Quantum Magnetic Resonance Therapy (QMRT) present attractive future growth opportunities. Traditional organ transplants remain a more cost-effective alternative currently and are a challenge the industry must overcome. The tissue engineering ecosystem involves hospitals, clinics, technology providers, regulatory bodies, and collaborative networks all working together to advance tissue engineering solutions. Sca...
Read more